Mercer Island, WA, United States of America

Ian Sweet

This inventor holds 1 USPTO granted patent. Top assignees: Entox Sciences, Inc., University of Washington. Active years: 2024.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ian Sweet - Innovator in Microperfusion Technology

Introduction

Ian Sweet is a notable inventor based in Mercer Island, WA (US). He has made significant contributions to the field of microperfusion technology, particularly with his innovative patent that addresses fluid dynamics in biological applications. His work is essential for advancing research in tissue and cell perifusions.

Latest Patents

Ian Sweet holds a patent titled "Pressure-driven, adjustable throughput fluidics for tissue and cell perifusions." This microperifusion system includes at least one perifusate reservoir module with N receptacles and at least one port for communicating a pressurizing gas. The system is designed to create a sealed fluid communication between selected receptacles and microperifusion channels, allowing for precise control of fluid flow during microperifusion tests.

Career Highlights

Throughout his career, Ian has worked with esteemed organizations such as the University of Washington and Entox Sciences, Inc. His experience in these institutions has allowed him to develop and refine his innovative ideas in the field of fluidics and microperfusion.

Collaborations

Ian has collaborated with notable professionals in his field, including Gamal Khalil and Daniel Cook. These partnerships have contributed to the advancement of his research and the successful implementation of his patented technology.

Conclusion

Ian Sweet's contributions to microperfusion technology through his innovative patent demonstrate his commitment to advancing scientific research. His work continues to impact the field positively, paving the way for future innovations in tissue and cell perifusions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…